ArticleJournal of cancer research and clinical oncology2019

DA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphoma.

Xin-Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.